📰 Emmac Life Sciences News
Page 2 - Emmac Life Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Emmac Life Sciences. Real-time updates on events, politics, business and more.
April 22, 2021
(Unaudited data) In thousands of euros 2021 2020 Variation at current exchange rates Variation at constant exchange rates France 51,518 72,820 -29.3% -29.3% Europe
April 17, 2021
GrowGeneration Corp. (NASDAQ: GRWG)Innovative Industrial Properties, Inc. Innovative Industrial Properties, Inc. is a real estate company specifically focusing on leasing properties to licensed companies in the regulated U.S. cannabis industry. With its most recent expansion, IIP owns 68 properties across 18 states in the U.S. In April the company announced it entered into an agreement with a Jushi Holdings Inc. (OTC: JUSHF) subsidiary in Pennsylvania for a cannabis growing and processing facil...
April 8, 2021
Apr 8, 2021 at 10:40AM Follow @jimhalley If youre looking for marijuana stocks with the potential to double your investment this year, Harvest Health & Recreation (OTC:HRVSF), Curaleaf Planet 13 Holdings (OTC:PLNH.F) are good places to start. They all have significant tailwinds, are showing outstanding revenue growth, and are well-situated to grow their businesses this year. Theres still plenty of risk in marijuana stocks, with some wild price swings in sto...
April 1, 2021
Here's why Curaleaf Holdings (TSXV:CURA) continues to be my top pick for investors looking at companies with high leverage to U.S. legalization.
March 16, 2021
Horizons ETFs Made Waves When They Launched the World’s First Psychedelics Stock ETF on the NEO Exchange Early This Year The Dales Report sat down with Steve Hawkins, the President and CEO of Horizons ETFs for an interview, to learn a little bit more about the behind-the-scenes on creating a Psychedelics ETF like Horizons Psychedelic Stock Index ETF (NEO: PSYK) from scratch, what investors should know, and where the Psychedelics industry – and others – might be headed. Right now, H...
March 15, 2021
MONEYWEB app instead? Developments show that global receptiveness to marijuana is accelerating. By Tiffany Kary, Bloomberg 15 Mar 2021 07:45 Seemingly overnight, the cannabis industry has gone global. That can be seen in the deal just announced by Curaleaf Holdings Inc., the largest US cannabis company, that aims to turn Europe into a launchpad for international growth. Or take a look at British American Tobacco Plcâs new stake in a Canadian marijuana company, Organigram Holdings In...
March 12, 2021
Cannabis Curaleaf in $286 Million deal to expand in Europe. Curaleaf, the largest cannabis company in the U.S., is on its way to become the largest of its kind in the world after announcing a $286 million deal to acquire European marijuana company Emmac Life Sciences. Boris Jordan, the billionaire executive chairman of Curaleaf, said during the company’s earning’s call on Tuesday that the acquisition is a “transformational launching point” and will turn the company into a dominant forc...
March 11, 2021
Mar 12, 2021 09:10 pm By Chloe Aiello Share with U.S. cannabis company Curaleaf agreed to acquire London-based Emmac Life Sciences in a $286 million deal that represents the company’s first step into the burgeoning European cannabis market. “We think, although the market is just emerging, its the addressable opportunity in Europe could actually be bigger than the addressable opportunity in the U.S., and this gives us an unparalleled platform to be able to build on,” Curaleaf CEO Joe Bayer...
March 10, 2021
Curaleaf to Enter European Cannabis Market with Acquisition of EMMAC Life Sciences Limited - Europes Leading Independent Cannabis Company EMMAC Brings the Largest Vertically Integrated Independent Cannabis Company in Europe with a Presence in Key European Medical Cannabis Markets, Including the United Kingdom, Germany, Italy, Spain, and Portugal With the European Population of Nearly 748 Million 1, the Potential Addressable Market is More than Twice the Size of U.S. ...
March 9, 2021
Curaleaf Holdings Inc. agreed to buy Emmac Life Sciences Ltd. for about $285 million, giving the company entry into Europe’s rapidly growing cannabis market.